image
Healthcare - Biotechnology - NASDAQ - US
$ 3.29
-4.64 %
$ 9.87 M
Market Cap
3.13
P/E
BALANCE SHEET
13.7 M ASSETS
-26.59%
7.6 M LIABILITIES
4.56%
6.11 M EQUITY
-46.44%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Kiora Pharmaceuticals, Inc.
image
Current Assets 4.74 M
Cash & Short-Term Investments 2.45 M
Receivables 2.05 M
Other Current Assets 233 K
Non-Current Assets 8.97 M
Long-Term Investments 0
PP&E 115 K
Other Non-Current Assets 8.86 M
Current Liabilities 1.63 M
Accounts Payable 206 K
Short-Term Debt 94.1 K
Other Current Liabilities 1.33 M
Non-Current Liabilities 5.97 M
Long-Term Debt 59.8 K
Other Non-Current Liabilities 5.91 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
ASSETS
Cash & Cash Equivalents 2.5 6.0 7.9 1.2 3.8 8.0 7.8 3.6 8.4 0.2 0.5 2.0
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 2.0 1.4 0.5 91 K 4.86 K 18.4 K 23.7 K 53.8 K 0.9 25.3 K 35.1 K 38.7 K
Inventory 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.2 0.3 1.2 0.4 1.0 0.9 1.3 0.5 0.1 52.9 K 22.4 K 41.1 K
Total Current Assets 4.7 7.7 9.0 1.8 4.3 8.5 8.5 4.2 9.4 0.2 0.6 2.1
PP&E 0.1 0.2 0.3 30.6 K 16.8 K 43.5 K 55.8 K 38 K 0 1.26 K 2.98 K 8.44 K
Intangible Assets 8.8 10.7 8.7 9.7 4.1 4.2 5.4 5.4 0 0 0 0
Goodwill 0 0 0 3.5 1.5 1.5 5.4 5.4 0 0 0 0
Long Term Investments 0 49.3 K 45 K 45 K 45 K 45 K 45 K 0.1 78.8 K 0 0 0
Other Long Term Assets 45 K 82.3 K 88 K 0.1 0.1 76.7 K 0.4 0.1 20.2 K 1.2 0.1 0.3
Other Assets 1 0 0 0 0 0 0 0 0 0 0 0
Total Assets 13.7 18.7 18.1 15.2 10.1 14.3 14.3 9.7 9.5 1.4 0.7 2.3
LIABILITIES
Accounts Payable 0.2 1.0 0.2 0.4 0.2 63.7 K 0.7 1.4 0.4 0.6 13.7 K 0.1
Short Term Debt 94.1 K 0.2 0.2 0.3 0.2 4.72 K 11.2 K 12.6 K 0 3.2 2.0 34.2 K
Other Current Liabilities 1.3 2.1 1.2 1.3 1.0 1.1 1.8 1.7 1.1 1.3 0.5 0.6
Total Current Liabilities 1.6 3.3 1.6 1.8 1.4 3.9 14.8 7.3 3.4 5.0 2.6 0.7
Long Term Debt 59.8 K 0 90.6 K 0.3 0 0 4.86 K 16.1 K 0 0 0 0
Deferred Tax Income 0.8 0.7 0.6 0.7 0.4 0.3 0.2 1.5 0 0 0 0
Other Liabilities 5.1 3.3 3.9 2.5 1.7 1.2 1.2 1.2 0 0 36.4 36.4
Total Liabilities 7.6 7.3 8.8 8.2 3.5 5.3 16.2 10.1 3.4 41.4 39.0 37.2
EQUITY
Common Stock 77.1 K 18 K 0.1 55.6 K 40.8 K 0.4 0.2 0.1 76.6 K 2.02 K 1.84 K 1.83 K
Retained Earnings (147.0) (134.5) (124.7) (108.3) (100.2) (93.2) (91.8) (78.6) (65.3) (56.9) (55.1) (51.2)
Other Accumulative Comprehensive Income/Loss (0.2) (0.2) 86.4 K 802 0.1 0.1 0.1 0.1 0.1 56.5 K 52.9 K 39.1 K
Total Equity 6.1 11.4 9.2 7.0 6.6 8.9 (1.9) (0.3) 6.1 (40.0) (38.3) (34.8)
Total Liabilities and Equity 13.7 18.7 18.1 15.2 10.1 14.3 14.3 9.7 9.5 1.4 0.7 2.3
SHARES OUTSTANDING
Common Shares Outstanding 0.5 0.7 0.2 0.1 79.5 K 59.1 K 23.8 K 14.7 K 10.3 K 11.6 K 8.89 K 8.89 K